Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Genmab A/SAlnylam PharmaceuticalsMerck KGaAGALAPAGOS NV/SGRIFOLS S A/S
SymbolOTCMKTS:GNMSFNASDAQ:ALNYOTCMKTS:MKGAFNASDAQ:GLPGNASDAQ:GRFS
Price Information
Current Price$294.80$133.35$107.95$197.79$19.32
52 Week RangeN/ABuyN/AHoldBuy
Beat the Market™ Rank
Overall Score0.41.70.61.21.8
Analysis Score0.03.40.03.22.3
Community Score1.93.32.32.72.1
Dividend Score0.00.00.00.03.3
Ownership Score0.01.00.00.00.0
Earnings & Valuation Score0.00.60.60.01.3
Analyst Ratings
Consensus RecommendationN/ABuyN/AHoldBuy
Consensus Price TargetN/A$149.83N/A$229.00$22.50
% Upside from Price TargetN/A12.36% upsideN/A15.78% upside16.46% upside
Trade Information
Market Cap$18.99 billion$15.66 billion$14.83 billion$13.27 billion$13.82 billion
Beta0.561.90.81.280.86
Average Volume6,349794,090263101,487625,311
Sales & Book Value
Annual Revenue$804.57 million$219.75 million$18.09 billion$1.00 billion$5.71 billion
Price / Sales22.6069.680.7712.782.33
Cashflow$5.37 per shareN/A$35.51 per share$6.04 per share$1.60 per share
Price / Cash54.93N/A3.0432.7512.09
Book Value$34.47 per share$11.76 per share$155.24 per share$48.34 per share$11.56 per share
Price / Book8.5511.340.704.091.67
Profitability
Net Income$324.68 million$-886,120,000.00$1.48 billion$167.83 million$700.16 million
EPSN/A($8.11)N/A$5.46$1.17
Trailing P/E Ratio53.99N/A19.4577.8717.25
Forward P/E RatioN/AN/A12.79
P/E GrowthN/AN/AN/AN/A$1.06
Net Margins41.65%-310.01%22.17%15.42%13.31%
Return on Equity (ROE)19.10%-57.63%12.76%12.45%11.92%
Return on Assets (ROA)17.83%-35.70%5.82%6.07%4.91%
Dividend
Annual PayoutN/AN/AN/AN/A$0.34
Dividend YieldN/AN/AN/AN/A1.76%
Three-Year Dividend GrowthN/AN/AN/AN/A6.00%
Payout RatioN/AN/AN/AN/A29.06%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A2 Years
Debt
Debt-to-Equity Ratio0.01%0.20%0.48%0.01%0.95%
Current Ratio19.04%4.68%0.76%9.28%2.75%
Quick Ratio19.04%4.48%0.48%9.28%0.90%
Ownership Information
Institutional Ownership Percentage0.04%93.40%N/A11.71%17.88%
Insider Ownership PercentageN/A3.50%N/A2.91%N/A
Miscellaneous
Employees3771,32357,0711,00322,244
Shares Outstanding61.69 million114.82 million129.24 million64.82 million687.55 million
Next Earnings Date8/12/2020 (Estimated)8/4/2020 (Estimated)7/29/2020 (Estimated)7/23/2020 (Estimated)7/29/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.